Global Thymidine Market Outlook 2018-2023

Global thymidine market is estimated to expand at a substantial CAGR in the forecast period as the scope, product types, and its applications are increasing across the globe. Thymidine is also known as “Deoxythymidine” or “Deoxyribosyl thymine, or “Thymine Deoxy Riboside”. It is pyrimidine deoxy nucleoside. It is a pharmaceutical intermediate that used to make anti-AIDS drugs “Zidovudine”.

Factors such as increased use of thymidine in numerous fields, increasing research and developmental activities, increasing government funding are likely to drive the thymidine market in the forthcoming period. However, technological advancements in healthcare are likely to create lucrative opportunities for the market.

Thymidine market is segmented by type, application, distribution channel, and geography. Market is segmented based on type as Fermentation Method and Chemical Synthesis Method. Market is segmented based on the application as anti-AIDS drugs and Others. The “anti-AIDS drugs” segment accounted for a prominent share in the market. It is likely to witness substantial growth in the years to come. Market is segmented based on distribution channel as Offline and Online. 

Thymidine market is categorized based on geography into North America, Latin America, Japan, Middle East, and Africa, Western Europe, Asia Pacific, and Eastern Europe. North America is a leading region in the market. It is likely to maintain its dominance in the forecast period owing to factors such as increasing demand from the end-user sector, use of progressive technology, and extensive use in the pharmaceutical and healthcare sector. North America is followed by the Asia-Pacific region. 

Leading players operating in the thymidine market include ST Pharm, Lonza, Zhejiang NHU, Carbopharm GmbH, Anhui Golden Sun Biopharmaceuticals, Zhejiang xianfeng Science Technology, Hebei Anminuo, and Wuhan Fortuna Chemical. The leading companies are involved in partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

The report segments the market and forecasts its size, by volume and value, on the basis of product, by application, and by geography (North America, Europe, Asia-Pacific, MEA and South America).

The report covers forecast and analysis for the thymidine market on a global and regional level. The study provides historic data of 2013-2017 along with a forecast from 2018 to 2023 based on both output/volume and revenue. The study then describes the drivers and restraints for the thymidine market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the thymidine market on a global level.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the global thymidine market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile.

The research report provides analysis and information according to market segments such as geographies, types and applications. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2023. Relevantly, the report and company profiles specify the key drivers that are impacting the demand in global thymidine market.

Key Regions
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South America

Key Vendors
- request free sample to get a complete list of companies

Key Questions Answered in this Report
- What will the market size be in 2023?
- What are the key factors driving the global thymidine market?
- What are the challenges to market growth?
- Who are the key players in the thymidine market?
- What are the market opportunities and threats faced by the key players?